Count | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
Norpregnenes/administration & dosage/adverse effects/*pharmacology | 2 |
| 1 | |
| 1 | |
| 6 | |
| 2 | |
| 10 | |
| 2 | |
| 4 | |
| 3 | |
| 5 | |
| 9 | |
| 3 | |
| 1 | |
| 1 | |
| 3 | |
| 5 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
Norpregnenes/administration & dosage/blood/*pharmacokinetics | 1 |
Norpregnenes/administration & dosage/chemistry/*pharmacokinetics | 1 |
Norpregnenes/*chemical synthesis/metabolism/pharmacokinetics | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 4 | |
| 3 | |
| 5 | |
| 5 | |
| 2 | |
| 4 | |
| 2 | |
| 17 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 10 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 10 | |
| 11 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |
| 2 | |
| 2 | |